首页 > 最新文献

Actas urologicas espanolas最新文献

英文 中文
Satisfaction assessment study in patients (and their partners) with/without Peyronie’s disease and penile prosthesis implantation 对患有/未患有佩罗尼氏病和植入阴茎假体的患者(及其伴侣)进行满意度评估研究
Pub Date : 2024-06-01 DOI: 10.1016/j.acuroe.2024.02.003
E. Lledó García , F.J. González García , J. Jara Rascón , J. García Muñoz , E. Lledó Graell , M.A. Sánchez Ochoa , C. Hernández Fernández

Introduction and objective

Among the many treatments for erectile dysfunction, implantation of a penile prosthesis has been associated with high patient satisfaction rates. However, patients with coexistent Peyronie’s disease (PD) and refractory erectile dysfunction and/or severe deformities may show different results. The aim of our study was to assess and to compare the level of satisfaction, with an inflatable penile prosthesis (IPP), in men with/without coexistent PD.

Material and methods

A survey study based on a five-item satisfaction questionnaire was submitted to all those live patients implanted in the period 1992–2022 at our center (n = 570) and their partners. Ninety-two percent of implants were inflatable devices. Surgeries were mainly performed by two surgeons. The main outcome measure used was the level of patient and partner satisfaction with sexual intercourse after IPP.

Results

Of the 570 eligible patients, 479 (84%) completed the survey (393 Non-PD: GROUP 1; 70 non-complex PD-Group 2; 16 complex PD). Eighty-six per cent of patients in Group 1 reported satisfactory sexual intercourse (very or moderately satisfied). Non-complex PD implanted patients (Group 2) reported a global 81% satisfactory sexual intercourse (very or moderately satisfied) (p > 0.05). However, when we evaluated the PD subgroup of patients with severe PD who require incision/excision/grafting at the time of implant (Group 3: n = 20), only 61% reported satisfactory sexual intercourse (p < 0.01) with predominance of moderately satisfied patients over very satisfied: 78% vs. 22%). Additionally, 84% (Group 1), 80% (Group 2) and 54% (Group 3) of partners reported satisfactory intercourses, respectively (p < 0.01). Overall, 84% of Group 1 implants and 79% of Group 2 reported that they would undergo the procedure again if the IPP failed (p > 0.05; ns). Only 50% of Group 3 patients would do it again. With regard to cosmetic aspects, 48% of the Group 3 implant reported penile shortness or soft glans as the main causes of their dissatisfaction. Only 2.4% of total PP patients expressed difficulty in manipulating the device.

Conclusion

The presence of PD alone may not impact PP patient and partner satisfaction, but patients with more severe baseline deformity who require incision/grafting may be less satisfied with outcomes including penile length and glans sensation.

简介和目的在众多治疗勃起功能障碍的方法中,植入阴茎假体的患者满意度较高。然而,同时患有佩罗尼氏病(PD)、难治性勃起功能障碍和/或严重畸形的患者可能会显示出不同的结果。我们的研究旨在评估和比较同时患有/未患有佩罗尼氏病的男性对充气阴茎假体(IPP)的满意度。材料和方法我们向 1992-2022 年期间在本中心植入假体的所有活体患者(570 人)及其伴侣发放了五项满意度调查问卷。92%的植入物为充气装置。手术主要由两名外科医生进行。结果 在 570 名符合条件的患者中,479 人(84%)完成了调查(393 名非复杂性前列腺增生症患者:第 1 组;70 名非复杂性前列腺增生症患者-第 2 组;16 名复杂性前列腺增生症患者)。在第 1 组中,86% 的患者表示性交满意(非常满意或中度满意)。非复杂性前列腺增生症植入患者(第 2 组)的总体满意度为 81%(非常满意或基本满意)(p > 0.05)。然而,当我们对需要在植入时进行切口/切除/移植手术的重度假体植入患者(第 3 组:n = 20)的假体植入亚组进行评估时,只有 61% 的患者报告了满意的性生活(p <0.01),其中中度满意的患者多于非常满意的患者:78%对22%)。此外,84%(第 1 组)、80%(第 2 组)和 54%(第 3 组)的伴侣对性交表示满意(p < 0.01)。总体而言,84% 的第一组植入者和 79% 的第二组植入者表示,如果 IPP 失败,他们会再次接受手术(p > 0.05; ns)。只有 50%的第 3 组患者会再次接受手术。在外观方面,第 3 组植入者中有 48% 表示阴茎短小或龟头软是他们不满意的主要原因。结论单纯的阴茎短小症可能不会影响阴茎短小症患者和伴侣的满意度,但基线畸形较严重且需要切开/移植的患者可能对阴茎长度和龟头感觉等结果不太满意。
{"title":"Satisfaction assessment study in patients (and their partners) with/without Peyronie’s disease and penile prosthesis implantation","authors":"E. Lledó García ,&nbsp;F.J. González García ,&nbsp;J. Jara Rascón ,&nbsp;J. García Muñoz ,&nbsp;E. Lledó Graell ,&nbsp;M.A. Sánchez Ochoa ,&nbsp;C. Hernández Fernández","doi":"10.1016/j.acuroe.2024.02.003","DOIUrl":"10.1016/j.acuroe.2024.02.003","url":null,"abstract":"<div><h3>Introduction and objective</h3><p>Among the many treatments for erectile dysfunction, implantation of a penile prosthesis has been associated with high patient satisfaction rates. However, patients with coexistent Peyronie’s disease (PD) and refractory erectile dysfunction and/or severe deformities may show different results. The aim of our study was to assess and to compare the level of satisfaction, with an inflatable penile prosthesis (IPP), in men with/without coexistent PD.</p></div><div><h3>Material and methods</h3><p>A survey study based on a five-item satisfaction questionnaire was submitted to all those live patients implanted in the period 1992–2022 at our center (n<!--> <!-->=<!--> <!-->570) and their partners. Ninety-two percent of implants were inflatable devices. Surgeries were mainly performed by two surgeons. The main outcome measure used was the level of patient and partner satisfaction with sexual intercourse after IPP.</p></div><div><h3>Results</h3><p>Of the 570 eligible patients, 479 (84%) completed the survey (393 Non-PD: GROUP 1; 70 non-complex PD-Group 2; 16 complex PD). Eighty-six per cent of patients in Group 1 reported satisfactory sexual intercourse (very or moderately satisfied). Non-complex PD implanted patients (Group 2) reported a global 81% satisfactory sexual intercourse (very or moderately satisfied) (p<!--> <!-->&gt;<!--> <!-->0.05). However, when we evaluated the PD subgroup of patients with severe PD who require incision/excision/grafting at the time of implant (Group 3: n<!--> <!-->=<!--> <!-->20), only 61% reported satisfactory sexual intercourse (p<!--> <!-->&lt;<!--> <!-->0.01) with predominance of moderately satisfied patients over very satisfied: 78% vs. 22%). Additionally, 84% (Group 1), 80% (Group 2) and 54% (Group 3) of partners reported satisfactory intercourses, respectively (p<!--> <!-->&lt;<!--> <!-->0.01). Overall, 84% of Group 1 implants and 79% of Group 2 reported that they would undergo the procedure again if the IPP failed (p<!--> <!-->&gt;<!--> <!-->0.05; ns). Only 50% of Group 3 patients would do it again. With regard to cosmetic aspects, 48% of the Group 3 implant reported penile shortness or soft glans as the main causes of their dissatisfaction. Only 2.4% of total PP patients expressed difficulty in manipulating the device.</p></div><div><h3>Conclusion</h3><p>The presence of PD alone may not impact PP patient and partner satisfaction, but patients with more severe baseline deformity who require incision/grafting may be less satisfied with outcomes including penile length and glans sensation.</p></div>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139876417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New frontiers in kidney transplantation: Towards the extended reality 肾移植的新领域:走向扩展现实。
Pub Date : 2024-06-01 DOI: 10.1016/j.acuroe.2023.11.005
Alberto Piana , Alessio Pecoraro , Muhammet İrfan Dönmez , Thomas Prudhomme , Beatriz Bañuelos Marco , Alicia López Abad , Riccardo Campi , Romain Boissier , Enrico Checcucci , Daniele Amparore , Francesco Porpiglia , Alberto Breda , Angelo Territo , en representación del grupo de trasplante renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU)
{"title":"New frontiers in kidney transplantation: Towards the extended reality","authors":"Alberto Piana ,&nbsp;Alessio Pecoraro ,&nbsp;Muhammet İrfan Dönmez ,&nbsp;Thomas Prudhomme ,&nbsp;Beatriz Bañuelos Marco ,&nbsp;Alicia López Abad ,&nbsp;Riccardo Campi ,&nbsp;Romain Boissier ,&nbsp;Enrico Checcucci ,&nbsp;Daniele Amparore ,&nbsp;Francesco Porpiglia ,&nbsp;Alberto Breda ,&nbsp;Angelo Territo ,&nbsp;en representación del grupo de trasplante renal de la sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU)","doi":"10.1016/j.acuroe.2023.11.005","DOIUrl":"10.1016/j.acuroe.2023.11.005","url":null,"abstract":"","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138049120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of telehealth on incontinence severity given to women with urinary incontinence: A systematic review and meta-analysis of randomized controlled trials 远程保健对尿失禁妇女尿失禁严重程度的影响:随机对照试验的系统回顾和荟萃分析。
Pub Date : 2024-06-01 DOI: 10.1016/j.acuroe.2024.02.002
A.Y. Karaahmet , F.Ş. Bilgiç , N. Kızılkaya Beji

Introduction

Although urinary incontinence does not cause mortality, it is a global health problem that adversely affects the quality of life and health of women.

Objective

The aim of this study was to conduct a systematic review and meta-analysis of the studies investigating the effect of telehealth given to women with urinary incontinence (UI) on the severity of incontinence.

Methods

The literature review for this systematic review was conducted between August-Semptember 2023 using four electronic databases. Y-based articles were scanned using MeSH-based keywords. Randomized Controlled Trials conducted over the last decade were included in the screening.

Results

The analysis included six studies involving 826 women with UI. After telehealth intervention, there was a significant difference in UI symptom severity (MD: −2.14 95% CI: −2.67 to −1.62, Z = 8.03, p < 0.00001) and quality of life (SMD: −2.14 95% CI: −2.67 to −1.62, Z = 8.03, p < 0.00001) compared to the control groups. It had no effect on sexuality (MD: −4.65 95% CI: −9.60 to 0.30, Z = 1.84, p = 0.07), and anxiety (SMD: −0.15, 95% CI: −0.38 to 0.08, Z = 1.27, p = 0.21).

Conclusion

In this analysis, it was found that telehealth interventions performed on women with UI increased the quality of life while reducing the severity of incontinence in women, but had no effect on sexuality, and anxiety.

简介:尽管尿失禁不会导致死亡,但它是一个全球性的健康问题,对生活质量和健康造成了不利影响:尽管尿失禁不会导致死亡,但它是一个全球性的健康问题,对妇女的生活质量和健康造成了不利影响:本研究旨在对有关远程医疗对尿失禁(UI)女性严重程度的影响的研究进行系统回顾和荟萃分析:本系统性综述的文献综述于 2023 年 8 月至 9 月期间通过四个电子数据库进行。使用基于 MeSH 的关键词对基于 Y 的文章进行了扫描。筛选范围包括过去十年间进行的随机对照试验:分析包括六项研究,涉及 826 名患有尿失禁的妇女。经过远程保健干预后,尿失禁症状的严重程度有显著差异(MD:-2.14 95% CI:-2.67 to-1.62, Z = 8.03,p 结论:远程保健干预后,尿失禁症状的严重程度有显著差异:在这项分析中发现,对患有尿失禁的妇女进行远程保健干预可提高其生活质量,同时降低尿失禁的严重程度,但对性生活和焦虑没有影响。
{"title":"The effect of telehealth on incontinence severity given to women with urinary incontinence: A systematic review and meta-analysis of randomized controlled trials","authors":"A.Y. Karaahmet ,&nbsp;F.Ş. Bilgiç ,&nbsp;N. Kızılkaya Beji","doi":"10.1016/j.acuroe.2024.02.002","DOIUrl":"10.1016/j.acuroe.2024.02.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Although urinary incontinence does not cause mortality, it is a global health problem that adversely affects the quality of life and health of women.</p></div><div><h3>Objective</h3><p>The aim of this study was to conduct a systematic review and meta-analysis of the studies investigating the effect of telehealth given to women with urinary incontinence (UI) on the severity of incontinence.</p></div><div><h3>Methods</h3><p>The literature review for this systematic review was conducted between August-Semptember 2023 using four electronic databases. Y-based articles were scanned using MeSH-based keywords. Randomized Controlled Trials conducted over the last decade were included in the screening.</p></div><div><h3>Results</h3><p>The analysis included six studies involving 826 women with UI. After telehealth intervention, there was a significant difference in UI symptom severity (MD: −2.14 95% CI: −2.67 to −1.62, <em>Z</em> <!-->=<!--> <!-->8.03, <em>p</em> <!-->&lt;<!--> <!-->0.00001) and quality of life (SMD: −2.14 95% CI: −2.67 to −1.62, Z<!--> <!-->=<!--> <!-->8.03, <em>p</em> <!-->&lt;<!--> <!-->0.00001) compared to the control groups. It had no effect on sexuality (MD: −4.65 95% CI: −9.60 to 0.30, Z<!--> <!-->=<!--> <!-->1.84, <em>p</em> <!-->=<!--> <!-->0.07), and anxiety (SMD: −0.15, 95% CI: −0.38 to 0.08, <em>Z</em> <!-->=<!--> <!-->1.27, <em>p</em> <!-->=<!--> <!-->0.21).</p></div><div><h3>Conclusion</h3><p>In this analysis, it was found that telehealth interventions performed on women with UI increased the quality of life while reducing the severity of incontinence in women, but had no effect on sexuality, and anxiety.</p></div>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139743093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of laparoscopic surgery on the outcomes of radical cystectomy within a multimodal rehabilitation protocol 多模式康复方案中腹腔镜手术对根治性膀胱切除术疗效的影响
Pub Date : 2024-06-01 DOI: 10.1016/j.acuroe.2024.01.001
L. Muñiz Suárez , J. Subirá Ríos , P. Gayarre Abril , A. Montero Martorán , J.I. Hijazo Conejos , J. García Alarcón , J. García-Magariño Alonso , P. Medrano Llorente , M. Ramírez Fabián , F.X. Elizalde Benito , C. Murillo Pérez , M. Utrilla Ibuarben , A. Asensio Matas , C. Marín Zaldívar , R. Casans Francés , J.M. Ramírez Rodríguez , B. Blasco Beltrán , P. Carrera-Lasfuentes

Introduction and objective

The implementation of Enhanced Recover After Surgery (ERAS) multimodal rehabilitation protocols in radical cystectomy has shown to improve outcomes in hospital stay and complications. The aim of this analysis is to evaluate the impact of laparoscopic surgery on radical cystectomy within a multimodal rehabilitation program.

Material and methods

The study was carried out in a third level center between 2011 and 2020 including patients with bladder cancer submitted to radical cystectomy according to an ERAS (Enhanced Recovery After Surgery) protocol and the Spanish Multimodal Rehabilitation Group (GERM) with 20 items to be fulfilled.

Results

A total of 250 radical cystectomies were performed throughout the study period, 42.8% by open surgery (OS) and 57.2% by laparoscopic surgery (LS). The groups are comparable in demographic and clinical variables (p > 0.05).

Operative time was longer in the LS group (248.4 ± 55.0 vs. 286.2 ± 51.9 min; p < 0.001). However, bleeding was significantly lower in the LS group (417.5 ± 365.7 vs. 877.9 ± 529.7 cc; p < 0.001), as was the need for blood transfusion (33.6% vs. 58.9%; p < 0.001). Postoperative length of stay (11.5 ± 10.5 vs. 20.1 ± 17.2 days; p < 0.001), total and major complications were also significantly lower in this group (LS). The readmission rate was lower in the LS group but not significantly (36.4% vs. 29.4%; p = 0.237). The difference between 90-day mortality in both groups was not statistically significant (2.8% LS vs. 4.3% OS; p = 0.546). The differences were maintained in the multivariate models.

Conclusions

Laparoscopic surgery within a multimodal rehabilitation program increases operative time but significantly decreases intraoperative bleeding, transfusion requirements, postoperative length of stay, and complications.

导言和目的在根治性膀胱切除术中实施术后增强康复(ERAS)多模式康复方案已被证明可改善住院时间和并发症的治疗效果。这项分析旨在评估腹腔镜手术在多模式康复计划中对根治性膀胱切除术的影响。材料和方法这项研究于2011年至2020年间在一家三级中心进行,研究对象包括根据ERAS(术后强化康复)方案和西班牙多模式康复小组(GERM)的20项要求接受根治性膀胱切除术的膀胱癌患者。结果 整个研究期间共进行了250例根治性膀胱切除术,其中42.8%采用开放手术(OS),57.2%采用腹腔镜手术(LS)。LS组的手术时间更长(248.4 ± 55.0 vs. 286.2 ± 51.9 min; p <0.001)。然而,LS 组的出血量(417.5 ± 365.7 对 877.9 ± 529.7 cc;p <;0.001)和输血需求(33.6% 对 58.9%;p <;0.001)明显较低。术后住院时间(11.5 ± 10.5 对 20.1 ± 17.2 天;p <;0.001)、总并发症和主要并发症在该组(LS)中也明显较低。LS组的再入院率较低,但并不明显(36.4% vs. 29.4%; p = 0.237)。两组的 90 天死亡率差异无统计学意义(2.8% LS vs. 4.3% OS; p = 0.546)。结论在多模式康复计划内进行腹腔镜手术会增加手术时间,但会显著减少术中出血、输血需求、术后住院时间和并发症。
{"title":"Influence of laparoscopic surgery on the outcomes of radical cystectomy within a multimodal rehabilitation protocol","authors":"L. Muñiz Suárez ,&nbsp;J. Subirá Ríos ,&nbsp;P. Gayarre Abril ,&nbsp;A. Montero Martorán ,&nbsp;J.I. Hijazo Conejos ,&nbsp;J. García Alarcón ,&nbsp;J. García-Magariño Alonso ,&nbsp;P. Medrano Llorente ,&nbsp;M. Ramírez Fabián ,&nbsp;F.X. Elizalde Benito ,&nbsp;C. Murillo Pérez ,&nbsp;M. Utrilla Ibuarben ,&nbsp;A. Asensio Matas ,&nbsp;C. Marín Zaldívar ,&nbsp;R. Casans Francés ,&nbsp;J.M. Ramírez Rodríguez ,&nbsp;B. Blasco Beltrán ,&nbsp;P. Carrera-Lasfuentes","doi":"10.1016/j.acuroe.2024.01.001","DOIUrl":"10.1016/j.acuroe.2024.01.001","url":null,"abstract":"<div><h3>Introduction and objective</h3><p>The implementation of Enhanced Recover After Surgery (ERAS) multimodal rehabilitation protocols in radical cystectomy has shown to improve outcomes in hospital stay and complications. The aim of this analysis is to evaluate the impact of laparoscopic surgery on radical cystectomy within a multimodal rehabilitation program.</p></div><div><h3>Material and methods</h3><p>The study was carried out in a third level center between 2011 and 2020 including patients with bladder cancer submitted to radical cystectomy according to an ERAS (Enhanced Recovery After Surgery) protocol and the Spanish Multimodal Rehabilitation Group (GERM) with 20 items to be fulfilled.</p></div><div><h3>Results</h3><p>A total of 250 radical cystectomies were performed throughout the study period, 42.8% by open surgery (OS) and 57.2% by laparoscopic surgery (LS). The groups are comparable in demographic and clinical variables (<em>p</em> &gt; 0.05).</p><p>Operative time was longer in the LS group (248.4 ± 55.0 vs. 286.2 ± 51.9 min; <em>p</em> &lt; 0.001). However, bleeding was significantly lower in the LS group (417.5 ± 365.7 vs. 877.9 ± 529.7 cc; <em>p</em> &lt; 0.001), as was the need for blood transfusion (33.6% vs. 58.9%; <em>p</em> &lt; 0.001). Postoperative length of stay (11.5 ± 10.5 vs. 20.1 ± 17.2 days; <em>p</em> &lt; 0.001), total and major complications were also significantly lower in this group (LS). The readmission rate was lower in the LS group but not significantly (36.4% vs. 29.4%; <em>p</em> = 0.237). The difference between 90-day mortality in both groups was not statistically significant (2.8% LS vs. 4.3% OS; <em>p</em> = 0.546). The differences were maintained in the multivariate models.</p></div><div><h3>Conclusions</h3><p>Laparoscopic surgery within a multimodal rehabilitation program increases operative time but significantly decreases intraoperative bleeding, transfusion requirements, postoperative length of stay, and complications.</p></div>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139393469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Informed consent in urology 泌尿外科的知情同意
Pub Date : 2024-06-01 DOI: 10.1016/j.acuroe.2024.01.005
C. Vargas Blasco , C. Martin-Fumadó , J. Arimany Manso

Appropriate professional practice includes the diagnostic and treatment process of urologic pathology, as well as patient information and respect for patient autonomy in decision making. Informed consent is the gradual process of providing information to the patient and their subsequent decision making. The informed consent document (ICD), when required, demonstrates that information has been provided sufficiently in advance to allow for the patient’s deliberation. The dual need for simple yet complete documents make the preparation of adequate ICDs extremely difficult. If the information process is not carried out properly, the professional may incur a medical malpractice liability that is treated as a loss of opportunity. To avoid such situations, the work of scientific societies in the preparation, accessibility, and dissemination of ICD models is fundamental.

适当的专业实践包括泌尿科病理学的诊断和治疗过程,以及向患者提供信息和尊重患者的决策自主权。知情同意是向患者提供信息并由其做出决定的渐进过程。必要时,知情同意文件 (ICD) 可证明已提前充分提供信息,以便患者进行深思熟虑。对简单而完整的文件的双重需求,使得准备充分的 ICD 极其困难。如果信息流程执行不当,专业人员可能会承担医疗事故责任,被视为机会损失。为了避免出现这种情况,科学协会在 ICD 模型的准备、可获取性和传播方面的工作至关重要。
{"title":"Informed consent in urology","authors":"C. Vargas Blasco ,&nbsp;C. Martin-Fumadó ,&nbsp;J. Arimany Manso","doi":"10.1016/j.acuroe.2024.01.005","DOIUrl":"10.1016/j.acuroe.2024.01.005","url":null,"abstract":"<div><p><span>Appropriate professional practice includes the diagnostic and treatment process of urologic pathology, as well as patient information and respect for patient autonomy in decision making. </span>Informed consent is the gradual process of providing information to the patient and their subsequent decision making. The informed consent document (ICD), when required, demonstrates that information has been provided sufficiently in advance to allow for the patient’s deliberation. The dual need for simple yet complete documents make the preparation of adequate ICDs extremely difficult. If the information process is not carried out properly, the professional may incur a medical malpractice liability that is treated as a loss of opportunity. To avoid such situations, the work of scientific societies in the preparation, accessibility, and dissemination of ICD models is fundamental.</p></div>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139391701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is trimodal therapy the current standard for muscle-invasive bladder cancer? 三联疗法是目前治疗肌肉浸润性膀胱癌的标准吗?
Pub Date : 2024-06-01 DOI: 10.1016/j.acuroe.2024.04.001
M. López Valcárcel , M. Barrado Los Arcos , M. Ferri Molina , I. Cienfuegos Belmonte , V. Duque Santana , P. Gajate Borau , J. Fernández Ibiza , M. Álvarez Maestro , P. Sargos , F. López Campos , F. Couñago

Objective

The aim of this review is to summarize the current evidence and future perspectives of bladder-sparing treatment for MIBC.

Methods

A non-systematic literature search in Medline/Pubmed was performed in October 2023 with the following keywords “bladder cancer”, “bladder-sparing”, “trimodal therapy”, “chemoradiation”, “biomarkers”, “immunotherapy”, “neoadjuvant chemotherapy”, “radiotherapy”.

Results

Urology guidelines recommend radical cystectomy as the standard curative treatment for muscle-invasive urothelial bladder cancer, reserving radiotherapy for patients who are unfit or who want to preserve their bladder. Given the morbidity and mortality of cystectomy and its impact on quality of life and bladder function, modern oncologic therapies are increasingly oriented toward organ preservation and maximizing functional outcomes while maintaining treatment efficacy. Trimodal therapy, which incorporates maximal transurethral resection followed by radiotherapy with concurrent radiosensitizing chemotherapy, is an effective regimen for bladder function preservation in well-selected patients. Despite the absence of comparative data from randomized trials, the two approaches seem to provide comparable oncologic outcomes.

Studies are evaluating the expansion of eligibility criteria for trimodal therapy, the optimization of radiotherapy and immunotherapy delivery to further improve outcomes, and the validation of biomarkers to guide bladder preservation.

Conclusions

Trimodal therapy has shown acceptable outcomes for bladder preservation; therefore, it provides a valid treatment option in well-selected patients.

方法 2023 年 10 月在 Medline/Pubmed 上进行了非系统性文献检索,关键词为 "膀胱癌"、"保膀胱"、"三联疗法"、"化学放疗"、"生物标志物"、"免疫疗法"、"新辅助化疗"、"放疗"。结果 泌尿外科指南建议将根治性膀胱切除术作为肌层浸润性尿路上皮膀胱癌的标准根治性治疗方法,为不适合或希望保留膀胱的患者保留放疗。鉴于膀胱切除术的发病率和死亡率及其对生活质量和膀胱功能的影响,现代肿瘤疗法越来越倾向于在保持疗效的同时保留器官并最大限度地提高功能结果。三联疗法包括最大限度的经尿道切除术,然后进行放疗,并同时进行放射增敏化疗,对于经过严格筛选的患者来说,这是一种保留膀胱功能的有效方案。研究正在评估扩大三联疗法的资格标准、优化放疗和免疫疗法的给药方式以进一步改善疗效,以及验证生物标志物以指导膀胱功能保留。结论三联疗法在膀胱功能保留方面取得了可接受的疗效;因此,它为经过严格筛选的患者提供了有效的治疗选择。
{"title":"Is trimodal therapy the current standard for muscle-invasive bladder cancer?","authors":"M. López Valcárcel ,&nbsp;M. Barrado Los Arcos ,&nbsp;M. Ferri Molina ,&nbsp;I. Cienfuegos Belmonte ,&nbsp;V. Duque Santana ,&nbsp;P. Gajate Borau ,&nbsp;J. Fernández Ibiza ,&nbsp;M. Álvarez Maestro ,&nbsp;P. Sargos ,&nbsp;F. López Campos ,&nbsp;F. Couñago","doi":"10.1016/j.acuroe.2024.04.001","DOIUrl":"10.1016/j.acuroe.2024.04.001","url":null,"abstract":"<div><h3>Objective</h3><p>The aim of this review is to summarize the current evidence and future perspectives of bladder-sparing treatment for MIBC.</p></div><div><h3>Methods</h3><p>A non-systematic literature search in Medline/Pubmed was performed in October 2023 with the following keywords “bladder cancer”, “bladder-sparing”, “trimodal therapy”, “chemoradiation”, “biomarkers”, “immunotherapy”, “neoadjuvant chemotherapy”, “radiotherapy”.</p></div><div><h3>Results</h3><p>Urology guidelines recommend radical cystectomy as the standard curative treatment for muscle-invasive urothelial bladder cancer, reserving radiotherapy for patients who are unfit or who want to preserve their bladder. Given the morbidity and mortality of cystectomy and its impact on quality of life and bladder function, modern oncologic therapies are increasingly oriented toward organ preservation and maximizing functional outcomes while maintaining treatment efficacy. Trimodal therapy, which incorporates maximal transurethral resection followed by radiotherapy with concurrent radiosensitizing chemotherapy, is an effective regimen for bladder function preservation in well-selected patients. Despite the absence of comparative data from randomized trials, the two approaches seem to provide comparable oncologic outcomes.</p><p>Studies are evaluating the expansion of eligibility criteria for trimodal therapy, the optimization of radiotherapy and immunotherapy delivery to further improve outcomes, and the validation of biomarkers to guide bladder preservation.</p></div><div><h3>Conclusions</h3><p>Trimodal therapy has shown acceptable outcomes for bladder preservation; therefore, it provides a valid treatment option in well-selected patients.</p></div>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140795535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large retroperitoneal mass during pregnancy 妊娠期腹膜后巨大肿块。
Pub Date : 2024-06-01 DOI: 10.1016/j.acuroe.2024.01.004
J.M. Giménez-Bachs , M. Villar-García , A. Fernández-López , A.S. Salinas-Sánchez
{"title":"Large retroperitoneal mass during pregnancy","authors":"J.M. Giménez-Bachs ,&nbsp;M. Villar-García ,&nbsp;A. Fernández-López ,&nbsp;A.S. Salinas-Sánchez","doi":"10.1016/j.acuroe.2024.01.004","DOIUrl":"10.1016/j.acuroe.2024.01.004","url":null,"abstract":"","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139379099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial experience with thulium fiber laser for prostate enucleation: Analysis of the intraoperative and short-term outcomes in a prospective, multicenter cohort 使用铥光纤激光进行前列腺切除术的初步经验:前瞻性多中心队列术中和短期疗效分析。
Pub Date : 2024-06-01 DOI: 10.1016/j.acuroe.2024.02.010
J. Romero Otero , J. Justo Quintas , E. García Rojo , R. Sopeña Sutil , E. Peña Vallejo , F. Lista Mateos , G. Bozzini , D. Saenz Calzada , A. Rodríguez Antolín , B. García Gómez

Introduction

Holmium laser enucleation of the prostate has rapidly become the gold standard for the surgical treatment of benign prostate hyperplasia, although thulium fiber laser (TFL) has also been postulated as an effective and safe alternative for prostate enucleation. The aim of this study is to describe our initial experience with the TFL for endoscopic enucleation of the prostate.

Material and methods

All patients proposed to TFL prostate enucleation were included in the analysis, regardless their prostate volume, catheter status and severity of symptoms, in 3 centers. Preoperative characteristics, intraoperative times and functional 3-months follow-up variables were collected, along with complications.

Results

Fifty-six patients were available, with a mean age of 68.7 years. Enucleation and morcellation efficiencies were 2.04 and 7.47 g/min, respectively. Median hospital stay was one day. Comparable functional data, pre and 3-month post-surgery was: mean prostate volume 88.9 vs 21.3 g, maximum urinary flow 13.2 vs 27.3 ml/s, post-void residual volume 149 vs 7.8 ml, prostatic specific antigen level 11.2 vs 1 ng/ml, and International Prostate Symptom Score 20.75 vs 3.96. Fourteen out of 56 (25%) patients presented with complications grade ≤2, according to the Clavien-Dindo classification.

Discussion

With wider evidence for other urological indications, very recent evidence about the suitability of TFL for prostate enucleation has arisen, since the first case described in 2021. Our results seem to back up these previous successful experiences as long as we obtained good intraoperative and short term follow-up functional results. However, there is still a need of longer follow-up data.

Conclusions

TFL represents a novel technology for prostate enucleation, with a good intraoperative and short follow-up functional results, and a safety profile similar to the observed for those techniques that have been wider used for this indication. Further studies with longer follow-up periods and comparative with these other techniques are necessary.

导言:钬激光前列腺去核术已迅速成为手术治疗良性前列腺增生的金标准,尽管铥光纤激光(TFL)也被认为是前列腺去核术的一种有效而安全的替代方法。本研究旨在介绍我们使用铥光纤激光器进行内窥镜前列腺去核术的初步经验:分析对象包括3个中心所有拟行TFL前列腺摘除术的患者,无论其前列腺体积、导管状态和症状严重程度如何。收集了术前特征、术中时间、3个月功能随访变量以及并发症:结果:共有 56 名患者接受了手术,平均年龄为 68.7 岁。去核和去骨效率分别为2.04克/分钟和7.47克/分钟。住院时间中位数为一天。手术前和手术后三个月的功能数据比较如下:前列腺平均体积 88.9 vs 21.3 g,最大尿流 13.2 vs 27.3 ml/s,排尿后残余体积 149 vs 7.8 ml,前列腺特异抗原水平 11.2 vs 1 ng/ml,国际前列腺症状评分 20.75 vs 3.96。根据克拉维恩-丁多分类法,56名患者中有14名(25%)出现了≤2级并发症:讨论:随着其他泌尿外科适应症的证据越来越多,自2021年描述第一例前列腺摘除术以来,关于TFL是否适合前列腺摘除术的证据也在不断涌现。只要我们获得良好的术中和短期随访功能结果,我们的结果似乎就能证明之前的成功经验。然而,我们仍需要更长期的随访数据:结论:TFL是前列腺去核术的一种新技术,术中和短期随访功能结果良好,安全性与已广泛应用于该适应症的技术相似。有必要进行更长时间的随访研究,并与其他技术进行比较。
{"title":"Initial experience with thulium fiber laser for prostate enucleation: Analysis of the intraoperative and short-term outcomes in a prospective, multicenter cohort","authors":"J. Romero Otero ,&nbsp;J. Justo Quintas ,&nbsp;E. García Rojo ,&nbsp;R. Sopeña Sutil ,&nbsp;E. Peña Vallejo ,&nbsp;F. Lista Mateos ,&nbsp;G. Bozzini ,&nbsp;D. Saenz Calzada ,&nbsp;A. Rodríguez Antolín ,&nbsp;B. García Gómez","doi":"10.1016/j.acuroe.2024.02.010","DOIUrl":"10.1016/j.acuroe.2024.02.010","url":null,"abstract":"<div><h3>Introduction</h3><p>Holmium laser enucleation of the prostate has rapidly become the gold standard for the surgical treatment of benign prostate hyperplasia, although thulium fiber laser (TFL) has also been postulated as an effective and safe alternative for prostate enucleation. The aim of this study is to describe our initial experience with the TFL for endoscopic enucleation of the prostate.</p></div><div><h3>Material and methods</h3><p>All patients proposed to TFL prostate enucleation were included in the analysis, regardless their prostate volume, catheter status and severity of symptoms, in 3 centers. Preoperative characteristics, intraoperative times and functional 3-months follow-up variables were collected, along with complications.</p></div><div><h3>Results</h3><p>Fifty-six patients were available, with a mean age of 68.7 years. Enucleation and morcellation efficiencies were 2.04 and 7.47 g/min, respectively. Median hospital stay was one day. Comparable functional data, pre and 3-month post-surgery was: mean prostate volume 88.9 vs 21.3 g, maximum urinary flow 13.2 vs 27.3 ml/s, post-void residual volume 149 vs 7.8 ml, prostatic specific antigen level 11.2 vs 1 ng/ml, and International Prostate Symptom Score 20.75 vs 3.96. Fourteen out of 56 (25%) patients presented with complications grade ≤2, according to the Clavien-Dindo classification.</p></div><div><h3>Discussion</h3><p>With wider evidence for other urological indications, very recent evidence about the suitability of TFL for prostate enucleation has arisen, since the first case described in 2021. Our results seem to back up these previous successful experiences as long as we obtained good intraoperative and short term follow-up functional results. However, there is still a need of longer follow-up data.</p></div><div><h3>Conclusions</h3><p>TFL represents a novel technology for prostate enucleation, with a good intraoperative and short follow-up functional results, and a safety profile similar to the observed for those techniques that have been wider used for this indication. Further studies with longer follow-up periods and comparative with these other techniques are necessary.</p></div>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139901056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The leaky pipeline and gender gaps in urology. 泌尿外科的漏管和性别差距。
Pub Date : 2024-05-20 DOI: 10.1016/j.acuroe.2024.05.016
A Medina Gamero
{"title":"The leaky pipeline and gender gaps in urology.","authors":"A Medina Gamero","doi":"10.1016/j.acuroe.2024.05.016","DOIUrl":"10.1016/j.acuroe.2024.05.016","url":null,"abstract":"","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus update on the therapeutic approach to patients with neurogenic detrusor overactivity. 神经源性逼尿肌过度活动患者治疗方法的最新共识。
Pub Date : 2024-05-14 DOI: 10.1016/j.acuroe.2024.05.013
A Borau, J Salinas, M Allué, D Castro-Diaz, M Esteban, S Arlandis, M Virseda, J M Adot

Introduction and objectives: A Consensus document on the management of patients with neurogenic detrusor overactivity (NDO) was published in 2018. The present document aims to update its recommendations regarding treatment considering the new evidence available, and to contribute to the standardization of the management of this disorder.

Methods: The methodology used was based on a systematic review and the Nominal Group Technique. The clinical coordinator (CC) and the Consensus update group (CUG) defined the questions to be updated and carried out a systematic review to identify the new available evidence. After being evaluated by the expert panel, the relevant recommendations were updated and agreed in a consensus meeting.

Results: A total of 3210 publications were identified and 26 publications that met the inclusion criteria were included. The CUG updated 18 recommendations on the therapeutic approach to NDO. Unanimous consensus was reached on all of them.

Conclusions: Previous recommendations need to be revised due to the availability of new drugs, the increasing evidence on the use of botulinum toxin or neuromodulation procedures, and new surgical options.

导言和目标:2018 年发布了一份关于神经源性逼尿肌过度活动(NDO)患者管理的共识文件。本文件旨在根据现有的新证据更新其有关治疗的建议,并促进该疾病管理的标准化:采用的方法基于系统回顾和名义小组技术。临床协调员(CC)和共识更新小组(CUG)确定了需要更新的问题,并进行了系统回顾,以确定现有的新证据。经专家组评估后,更新了相关建议,并在共识会议上达成一致:结果:共确定了 3210 篇出版物,其中 26 篇符合纳入标准。CUG更新了18项关于NDO治疗方法的建议。所有建议均达成一致共识:结论:由于新药物的出现、使用肉毒杆菌毒素或神经调控程序的证据不断增加以及新的手术选择,以前的建议需要进行修订。
{"title":"Consensus update on the therapeutic approach to patients with neurogenic detrusor overactivity.","authors":"A Borau, J Salinas, M Allué, D Castro-Diaz, M Esteban, S Arlandis, M Virseda, J M Adot","doi":"10.1016/j.acuroe.2024.05.013","DOIUrl":"10.1016/j.acuroe.2024.05.013","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>A Consensus document on the management of patients with neurogenic detrusor overactivity (NDO) was published in 2018. The present document aims to update its recommendations regarding treatment considering the new evidence available, and to contribute to the standardization of the management of this disorder.</p><p><strong>Methods: </strong>The methodology used was based on a systematic review and the Nominal Group Technique. The clinical coordinator (CC) and the Consensus update group (CUG) defined the questions to be updated and carried out a systematic review to identify the new available evidence. After being evaluated by the expert panel, the relevant recommendations were updated and agreed in a consensus meeting.</p><p><strong>Results: </strong>A total of 3210 publications were identified and 26 publications that met the inclusion criteria were included. The CUG updated 18 recommendations on the therapeutic approach to NDO. Unanimous consensus was reached on all of them.</p><p><strong>Conclusions: </strong>Previous recommendations need to be revised due to the availability of new drugs, the increasing evidence on the use of botulinum toxin or neuromodulation procedures, and new surgical options.</p>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Actas urologicas espanolas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1